Wholesale of pharmaceutical and medical goods
INTRAORAL AS
Revenue 2025
NOK 2.1m
Operating profit
NOK 162,000
Equity
NOK 220,000
Incorporated
2021
Share capital
NOK 30,000
Key figures · 2025
Current ratio
4.49
Equity ratio
1.9%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 7.7% | |
| Net margin (%%) | 9.3% | |
| Return on assets (%%) | 1.4% | |
| Likviditet | ||
| Current ratio | 4.49 | |
| Working capital | 749k | |
| Soliditet | ||
| Equity ratio (%%) | 1.9% | |
| Debt-to-equity ratio | 51.64 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.